Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03849469
Title	A Study of XmAb22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (DUET-4)
Acronym	DUET-4
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Xencor, Inc.
Indications	endometrial carcinoma melanoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma triple-receptor negative breast cancer transitional cell carcinoma hepatocellular carcinoma cervix carcinoma nasopharynx carcinoma colorectal carcinoma pancreatic carcinoma lung non-small cell carcinoma gastric adenocarcinoma renal cell carcinoma lung small cell carcinoma
Therapies	Pembrolizumab + XmAb22841 XmAb22841
Age Groups:	senior \| adult
Covered Countries	USA